Celesio restructures to meet its Agenda 2015 targets
This article was originally published in Scrip
The German pharmaceutical wholesaler and retailer Celesio is taking steps to meet the targets set in Agenda 2015, its business development programme. Among other things, it wants to increase its profitability and reduce dependence both on government-regulated remuneration and on revenue tied to the pound sterling.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.